Literature DB >> 12430684

NAT screening of blood and plasma donations: evolution of technology and regulatory policy.

Edward Tabor1, Jay S Epstein.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12430684     DOI: 10.1046/j.1537-2995.2002.00183.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

Review 1.  Considerations for Group Testing: A Practical Approach for the Clinical Laboratory.

Authors:  Jun G Tan; Aznan Omar; Wendy By Lee; Moh S Wong
Journal:  Clin Biochem Rev       Date:  2020-12

2.  Informative Dorfman screening.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biometrics       Date:  2011-07-15       Impact factor: 2.571

Review 3.  New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Authors:  Mary C Kuhns; Michael P Busch
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.

Authors:  Paolo G V Martini; Lynette C Cook; Scott Alderucci; Angela W Norton; Dianna M Lundberg; Susan M Fish; Knut Langsetmo; Göran Jönsson; Christian Lood; Birgitta Gullstrand; Kate J Zaleski; Nancy Savioli; Jason Lottherand; Charles Bedard; John Gill; Michael F Concino; Michael W Heartlein; Lennart Truedsson; Jan L Powell; Arthur O Tzianabos
Journal:  BMC Immunol       Date:  2010-08-20       Impact factor: 3.615

5.  Use of dual TaqMan probes to increase the sensitivity of 1-step quantitative reverse transcription-PCR: application to the detection of SARS coronavirus.

Authors:  Shea Ping Yip; Shing Shun T To; Polly H M Leung; Tsz Shan Cheung; Peter K C Cheng; Wilina W L Lim
Journal:  Clin Chem       Date:  2005-10       Impact factor: 8.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.